Free Trial

AQR Capital Management LLC Has $79.34 Million Stock Position in Maximus, Inc. $MMS

Maximus logo with Business Services background

Key Points

  • AQR Capital Management LLC significantly increased its stake in Maximus, Inc. by 177.2%, acquiring an additional 750,031 shares to bring its total ownership to 1,173,329 shares, worth approximately $79.3 million.
  • Maximus reported better-than-expected quarterly earnings with $2.16 EPS, surpassing analysts' estimates by $0.77, and achieved revenue of $1.35 billion, above the estimated $1.29 billion.
  • The company declared a quarterly dividend of $0.30 per share, representing an annualized yield of 1.4%, with a current dividend payout ratio of 22.10%.
  • Five stocks to consider instead of Maximus.

AQR Capital Management LLC boosted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 177.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,173,329 shares of the health services provider's stock after buying an additional 750,031 shares during the period. AQR Capital Management LLC owned approximately 2.07% of Maximus worth $79,341,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Fuller & Thaler Asset Management Inc. increased its position in Maximus by 40.0% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock worth $117,921,000 after purchasing an additional 494,372 shares during the last quarter. SG Capital Management LLC acquired a new position in Maximus in the 4th quarter worth about $30,285,000. Reinhart Partners LLC. increased its position in Maximus by 65.4% in the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock worth $62,156,000 after purchasing an additional 360,365 shares during the last quarter. Boston Partners acquired a new position in Maximus in the 1st quarter worth about $20,983,000. Finally, Squarepoint Ops LLC acquired a new position in Maximus in the 4th quarter worth about $22,661,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

MMS has been the topic of several research reports. Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th. Zacks Research raised Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to data from MarketBeat.com, Maximus presently has an average rating of "Strong Buy" and a consensus target price of $90.00.

Get Our Latest Stock Report on Maximus

Maximus Stock Performance

MMS traded down $0.93 during trading on Tuesday, hitting $87.41. The stock had a trading volume of 591,056 shares, compared to its average volume of 569,126. The firm has a market cap of $4.93 billion, a PE ratio of 16.10 and a beta of 0.61. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.94. The company has a 50 day simple moving average of $78.56 and a 200-day simple moving average of $72.59.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period in the previous year, the company posted $1.74 earnings per share. The firm's revenue for the quarter was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's dividend payout ratio (DPR) is 22.10%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

See Also

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.